Search

everythinglearnresearchcommunity

for

Search:↓

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Minoxidil helps treat pattern hair loss in both men and women.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Azathioprine may help treat severe alopecia areata, but more research is needed.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Oral cyclosporine is an effective and safe treatment for severe alopecia areata.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

0.05% Betamethasone Dipropionate is the most effective topical treatment for alopecia areata.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

The SULT1A1 enzyme booster improves minoxidil effectiveness in treating hair loss, especially in females.

Topical tofacitinib is effective and safe for treating alopecia areata.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Betamethasone oral mini-pulse therapy showed good or fair results in treating lichen planus.